• Sylvie Chevret and Jean-Ralph Zahar.
• EA 11, Albert Bonniot Institute U823, Joseph Fourier University, Paris, France. jftimsit@chu-grenoble.fr
• Curr Opin Crit Care. 2011 Oct 1;17(5):464-71.

Purpose Of ReviewTo critically discuss the attributable mortality of ventilator-associated pneumonia (VAP) and potential sources of variation.Recent FindingsThe review will cover the available estimates (0-50%). It will also explore the source of variation because of definition of VAP (being lower if inaccurate), case-mix issues (being lower for trauma patients), the severity of underlying illnesses (being maximal when the severity of underlying illness is intermediate), and on the characteristics and the severity of the VAP episode. Another important source of variation is the use of poorly appropriate statistical models (estimates biased by lead time bias and competing events). New extensions of survival models which take into account the time dependence of VAP occurrence and competing risks allow less biased estimation as compared with traditional models.SummaryAttributable mortality of VAP is about 6%. Accurate diagnostic methods are key to properly estimating it. Traditional statistical models should no longer be used to estimate it. Prevention efforts targeted on patients with intermediate severity may result in the most important outcome benefits.

7 keywords...

hide…